Home - Products - Others - Other Targets - Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside

Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside

CAS No. 868557-54-4

Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside( —— )

Catalog No. M31830 CAS No. 868557-54-4

Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 666 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
  • Description
    Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    868557-54-4
  • Formula Weight
    418.4
  • Molecular Formula
    C18H26O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TNF-α (46-65), human...

    TNF-α (46-65), human (TFA) is a peptide of human TNF-α.

  • NLRP3/AIM2-IN-2

    NLRP3/AIM2-IN-2 is a novel potent inhibitor with different species-specific effects on NLRP3 and AIM2 inflammasome dependent pyroptosis with IC50 of 0.2392 ± 0.0233 μ M.

  • Myosin Kinase Inhibi...

    Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.